Cryptolepis buchanani aqueous extract. Int J Biol Chem 3 (2009): 90–94.
Soh, P. N., et al. Are West African plants a source of future antimalarial drugs? J Ethnopharmacol 114, no. 2 (2007): 130–40.
Tempesta, Michael S. The clinical efficacy of Cryptolepis sanguinolenta in the treatment of malaria. Ghana Med J 44, no. 1 (2010): 1–2.
Van Miert, S., et al. In vitro inhibition of betahaematin formation, DNA interactions, neocryptolepine derivatives. Exp Parasitol 108, no. 3–4 (2004): 163–68.
Van Miert, S., et al. Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound. J Nat Prod 68, no. 5 (2005): 674–77.
Venkateswara, R., et al. Cryptosin, a cardenolide from the leaves of Cryptolepis buchanani. Phytochemistry 28, no. 4 (1989): 1203–5.
Wright, C. W. Cryptolepine and development of new antimalarial agents. Iran J Pharm Res (IJPR) 3, suppl. 2 (2004): 17.
Wright, C. W. Recent developments in naturally derived antimalarials: cryptolepine analogues. J Pharm Pharmacol 59, no. 6 (2007): 899–904.
Yakubu, Clare Banoeng. “Nibima”: a wonder plant for malaria treatment for Ghana. Eyes on Malaria 3 (online). http://eyesonmalaria.org/nibima.html.
Yeau, K. L., et al. The cardiotonic effect of a glycoside from Cryptolepis buchanani. Yao Xue Xue Bao 10 (1963): 561–65.
Zhu, H., et al. Chemical compound review: cymopol. Entry on WikiGenes website at http://wikigenes.org/e/chem/e/5386672.html (accessed November 18, 2010).
Zhu, H., et al. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells. Oxford J Life Sci Med Tox Sci 91, no. 1 (2006): 132–39.
Zhu, X. Y., et al. Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antinfective agents. Bioorg Med Chem 15, no. 2 (2007): 686–95.
Aboulella, A. M., et al. Phytotherapeutic effects of Echinacea purpurea in gamma-irradiated mice. J Vet Sci 8, no. 4 (2007): 341–51.
Anonymous. Echinacea: Monograph. Altern Med Rev 6, no. 4 (2001): 411–14.
Binns, S. E., et al. Light-mediated antifungal activity of echinacea extracts. Planta Med 66, no. 3 (2000): 241–14.
Birt, D. F. Echinacea in infection. Am J Clin Nutr 87, no. 2 (2008): 488S–92S.
Brush, J., et al. The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytother Res 20, no. 8 (2006): 687–95.
Chaves, Fernando., et al. Effect of Echinacea purpurea (Asteraceae) aqueous extract on antibody response to Bothrops asper venom and immune cell response. Rev Biol Trop Int J Trop Biol 55, no. 1 (2007): 113–19.
Facino, R. M., et al. Echinacoside and caffeoyl conjugates protect collagen from free radicalinduced degradation: a potential use of echinacea extracts in the prevention of skin photodamage. Planta Med 61, no. 6 (1995): 510–14.
Fuchikama, H., et al. Effects of herbal extracts on the function of human organic aniontransporting polypeptide OATP-B. Drug Metab Dispos 34, no. 4 (2006): 577–82.
Jurkstiene, V., et al. Compensatory reactions of immune sytem and action of purple coneflower (Echinacea purpurea (L.) Moench) preparations. Medicina (Kaunas) 40, no. 7 (2004): 657–62.
Kim, L. S., et al. Immunological activity of larch arabinogalactan and echinacea: a preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev 7, no. 2 (2002): 138–49.
Kraus, G. A., et al. Synthesis and natural distribution of anti-inflammatory alkamides from echinacea. Molecule 11, no. 10 (2006): 758–67.
LaLone, C. A., et al. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells. J Agric Food Chem 55, no. 18 (2007): 7314–22.
Lee, T.-T., et al. Flavonoid, phenol and polysaccharide content of Echinacea purpurea L. and its immunostimulant capacity in vitro. Internl J Enviro Sci Dev 1, no. 1 (2010): 5–9.
McCann, D. A., et al. Cytokine– and interferonmodulating properties of Echinacea spp. root tinctures stored at –20 degrees C for 2 years. J Interferon Cytokine Res 27, no. 5 (2007): 425–36.
Melchart, D., et al. Results of five randomized studies on the immunomodulatory activity of preparations of echinacea. J Altern Complement Med 1, no. 2 (1995): 145–60.
Miller, Sandra C. Echinacea: a miracle herb against aging and cancer? Evidence in vivo in mice. Evid Based Complement Alternat Med 2, no. 3 (2005): 309–14.
Mishima, S., et al. Antioxidant and immunoenhancing effects of Echinacea purpurea. Biol Pharm Bull 27, no. 7 (2004): 1004–9.
Pleschka, S., et al. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H5N7) and swine-origin H1N1 (S-OIV). Virol J 13, no. 6 (2009): 197.
Raduner, S., et al. Alkylamides from echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and – independent immunomodulatory effects. J Biol Chem 281, no. 20 (2006): 14192–206.
Rininger, J. A., et al. Immunopharmacological activity of echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukocyt Biol 68 (2000): 503.
Roesler, J., et al. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharmacol 13, no. 1 (1991): 27–37.
Romiti, N., et al. P-glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line. Planta Med 74, no. 3 (2008): 264–66.
Rousseau, B., et al. Investigation of antihyaluronidase treatment on vocal fold wound healing. J Voice 20, no. 3 (2006): 443–51.
Senchina, D. S., et al. Phenetic comparison of seven echinacea species based on immunomodulatory characteristics. Econ Bot 60, no. 3 (2006):205–11.
Senchina, D. S., et al. Year-and-a-half old, dried echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination. Planta Med 72, no. 13 (2006): 1207–15.
Sharma, M., et al. The potential use of echinacea in acne: control of Propionibacterium acnes growth and inflammation. Phytother Res 25, no. 4 (2011): 517–21. E-pub (preprint) September 9, 2010.
Sharma, S. M., et al. Bactericidal and anti-inflammatory properties of a standardized echinacea extract (Echinaforce): dual actions against respiratory bacteria. Phytomedicine 17, no. 8–9 (2010): 563–68.
Soudi, S., et al. Antileishmanial effect of Echinacea purpurea root extract cultivated in Iran. Iran J Pharm Res 6, no. 2 (2007): 147–49.
Spence, Katherine M. In vivo evaluation of immunomodulatory properties of crude extracts of Echinacea species and fractions isolated from Echinacea purpurea. Master’s thesis, University of Southern Queensland (Toowoomba, Queensland), 1999. http://eprints.usq.edu.au/1512/.
Steinmüller, C., et al. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol 15, no. 5 (1993): 605–14.
Stevenson, L. M., et al. Modulation of macrophage immune responses by echinacea. Molecules 10 (2005): 1279–85.
Tamta, H., et al. Variability in in vitro macrophage activation by commercially diverse bulk echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharides. J Agric Food Chem 56, no. 22 (2008): 10552–56.
Tunnerhoff, F. H., et al. Research in man and animal on the effect of echinacea extracts on artificial formation of connective tissues after fibrin implantations. Arzneimittelforschung 6, no. 6 (1956): 330–34.
Wagner, H., et al. Immunostimulant action of polysaccharides (heteroglycans) from higher plants. Preliminary communication. Arzneimittelforschung 34, no. 6 (1984): 659–61.
Wagner, H., et al. Immunostimulating action of polysaccharides (heteroglycans) from higher plants. Arzneimittelforschung 35, no. 7 (1985): 1069–75.
Wang, C. Y., et al. Genomics and proteomics of immune modulatory effects of a butanol fraction of Echinacea purpurea in human dendritic cells. BMC Genomics 13, no. 9 (2008): 479.
Zaporozhets, O. A., et al. Medicinal plants: spectrophotometric determination of hydroxycynnamic acid and related compounds in echinacea preparations. Pharmaceutical Chem J 37, no. 12 (2003): 632.
Zhai, Z., et al. Alcohol extract of Echinacea pallida reverses stress-delayed wound healing in mice. Phytomedicine 16, no. 6–7 (2009): 669–78.
Zhai, Z., et al. Alcohol extracts of echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro. Food Agric Immunol 18, no. 3–4 (2007): 221–36.
Zhai, Z., et al. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. J Ethnopharmacol 122, no. 1 (2009): 76–85.
Zhai, Z., et al. Enhancement of innate and adaptive immune functions by multiple Echinacea species. J Med Food 10, no. 3 (2007): 423–34.